Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Cullinan Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 113 | 1 | 113 | +1 |
| Shares | 36.9M | 22.2K | 39.4M | +2.54M (+6.9%) |
| Value | $375.6M | $226.3K | $670.8M | +$295.5M (+78.7%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 1,348,015 | $23.0M | 0.81% |
| Deerfield Management Company, L.P. (Series C) | 1,138,531 | $19.4M | 0.34% |
| Adage Capital Partners GP, L.L.C. | 950,000 | $16.2M | 0.03% |
| Logos Global Management LP | 700,000 | $11.9M | 1.26% |
| PFM Health Sciences, LP | 255,967 | $4.36M | 0.22% |
| Rafferty Asset Management, LLC | 97,055 | $1.65M | 0.01% |
| Wellington Management Group LLP | 68,358 | $1.16M | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 36,401 | $620.3K | 0.00% |
| STRS Ohio | 31,900 | $543.0K | 0.00% |
| Nebula Research & Development LLC | 24,653 | $420.1K | 0.09% |
| Jump Financial, LLC | 21,690 | $369.6K | 0.01% |
| State of Wisconsin Investment Board | 20,095 | $342.4K | 0.00% |
| Profund Advisors LLC | 15,263 | $260.1K | 0.01% |
| Point72 (DIFC) Ltd | 1,273 | $21.7K | 0.00% |
| GWM Advisors LLC | 723 | $12.3K | 0.00% |
| Pacer Advisors, Inc. | 450 | $7.67K | 0.00% |
| Federated Hermes, Inc. | 244 | $4.16K | 0.00% |
| Group One Trading, L.P. | 14 | $239 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 5 | $85 | 0.00% |
Sold out (18)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Millennium Management LLC | 233,366 | $2.38M |
| Hudson Bay Capital Management LP | 225,000 | $2.29M |
| DAFNA Capital Management LLC | 127,284 | $1.30M |
| Verition Fund Management LLC | 112,873 | $1.15M |
| Two Sigma Investments, LP | 50,342 | $513.0K |
| Trexquant Investment LP | 34,955 | $356.2K |
| HSBC Holdings PLC | 21,816 | $221.2K |
| Squarepoint Ops LLC | 20,067 | $204.5K |
| Prelude Capital Management, LLC | 17,844 | $181.8K |
| Annandale Capital, LLC | 12,000 | $122.0K |
| Bailard, Inc. | 10,800 | $110.1K |
| Principal Financial Group Inc | 10,692 | $109.0K |
| Gsa Capital Partners LLP | 10,246 | $104.0K |
| Voya Investment Management LLC | 10,061 | $102.5K |
| Vontobel Holding Ltd. | 10,000 | $101.9K |
| Point72 Asia (Singapore) Pte. Ltd. | 2,852 | $29.1K |
| Russell Investments Group, Ltd. | 2,300 | $23.4K |
| Point72 Middle East FZE | 1,195 | $12.2K |
Not filed for Q1 2024 yet (1)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Putnam Investments LLC | 22,210 | $226.3K |